Dow component Johnson & Johnson reported an adjusted 2Q profit of $1.83 per share, topping the estimate for $1.80. Revenue for the company came in at $18.8 billion, short of the estimate for $18.94 billion.

Related Articles

• UnitedHealth tops 2Q expectations, hikes 2017 forecast

• German indicator of business optimism dips slightly

• Never Do This One Thing at Work